ImportRefusal LogoImportRefusal

Galderma Laboratories, L.P.

⚠️ High Risk

FEI: 1000118068 • Dallas, TX • UNITED STATES

FEI

FEI Number

1000118068

📍

Location

Dallas, TX

🇺🇸
🏢

Address

2001 Ross Ave Ste 1600, , Dallas, TX, United States

High Risk

FDA Import Risk Assessment

57.5
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

8
Total Refusals
3
Unique Violations
6/26/2025
Latest Refusal
7/16/2006
Earliest Refusal

Score Breakdown

Violation Severity
78.8×40%
Refusal Volume
35.3×30%
Recency
74.9×20%
Frequency
4.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1791×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

3411×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

Refusal History

DateProductViolationsDivision
6/26/2025
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
341REGISTERED
Division of Northeast Imports (DNEI)
6/10/2019
63VCO02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/1/2017
65QAK99RELAXANT N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/15/2012
61HDK99ANTI-BACTERIAL, N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/20/2012
62SDJ02ADAPALENE (ANTI-SEBORRHEIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/1/2009
62LCA40METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/24/2009
62SCY02ADAPALENE (ANTI-SEBORRHEIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
7/16/2006
64LCL28FLUOCINONIDE (GLUCOCORTICOID)
179AGR RX
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Galderma Laboratories, L.P.'s FDA import refusal history?

Galderma Laboratories, L.P. (FEI: 1000118068) has 8 FDA import refusal record(s) in our database, spanning from 7/16/2006 to 6/26/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Galderma Laboratories, L.P.'s FEI number is 1000118068.

What types of violations has Galderma Laboratories, L.P. received?

Galderma Laboratories, L.P. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Galderma Laboratories, L.P. come from?

All FDA import refusal data for Galderma Laboratories, L.P. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.